New insights into sympathetic regulation of glucose and fat metabolism

Diabetologia

Volumn 43, Issue 5, 2000, Pages 533-549

  Nonogaki, K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adrenergic; Diabetes; Glucose; Leptin; Obesity; Sympathetic

Indexed keywords

ADRENALIN; BETA 3 ADRENERGIC RECEPTOR; GLUCOSE; INSULIN; LEPTIN; LEPTIN RECEPTOR; MELANOCORTIN RECEPTOR; NORADRENALIN; SEROTONIN 2C RECEPTOR;

ADRENERGIC SYSTEM; DIABETES MELLITUS; GLUCOSE METABOLISM; HUMAN; HYPOTHALAMUS; LIPID METABOLISM; NEUROTRANSMISSION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; THERMOGENESIS;

ADIPOSE TISSUE; ANIMALS; AUTONOMIC NERVOUS SYSTEM; AUTONOMIC NERVOUS SYSTEM DISEASES; DIABETES MELLITUS, TYPE 2; GLUCOSE; HUMANS; LEPTIN; LIPID METABOLISM; LIVER; MUSCLE, SKELETAL; NOREPINEPHRINE; OBESITY; SYMPATHETIC NERVOUS SYSTEM;

EID: 0034077279     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051341     Document Type: Review

References (125)

1. 1. Friedman JM, Halaas JL (1998) Leptin and the regulation of body weight in mammals. Nature 395: 763-770
2. 2. Bray GA, York DA (1998) The Mona Lisa hypothesis in the time of leptin. Recent Prog Horm Res 53: 95-118
3. 3. Haynes WG, Sivitz W, Morgan DA, Walsh SA, Mark AL (1997) Sympathetic and cardiorenal actions of leptin. Hypertension 30: 619-623
4. 4. Saladin R, De Vos P, Guerre-Millo M et al. (1995) Transient increase in obese gene expression after food intake or insulin administration. Nature 377: 527-529
5. 5. Biden G, Chen X, Kolaczynski JW, Polansky M (1997) Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects. J Clin Invest 100: 1107-1113
6. 6. Barr VA, Malide D, Zarnowski MJ, Talor SI, Cushman SW (1997) Insulin stimulates both leptin secretion and production by rat white adipose tissue. Endocrinology 138: 4463-4472
7. 7. Mantzoros CS, Qu D, Frederich RC et al. (1996) Activation of β3 adrenergic receptors suppresses leptin expression and mediates a leptin-independent inhibition of food intake in mice. Diabetes 45: 909-914
8. 8. Nonogaki K (1999) Obesity: autonomic circuits versus feeding. Nat Med 5: 742-743
9. 9. Ahima RS, Prabakaran D, Mantzoros C et al. (1996) Role of leptin in the neuroendocrine response to fasting. Nature 382: 250-252
10. 10. Chehab FF, Lim ME, Lu R (1996) Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet 12: 318-320
11. 11. Licinio J, Mantzoros C, Negrao AB et al. (1997) Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nat Med 3: 575-579
12. 12. Orban Z, Bornstein SR, Chrousos GP (1998) The interaction between leptin and the hypothalamic-pituitary-thyroid axis. Horm Metab Res 30: 231-235
13. 13. Gardemann A, Puschel GP, Jungermann K (1992) Nervous control of liver metabolism and hemodynamics. Eur J Biochem 207: 399-411
14. 14. Shimazu T (1996) Innervation of the liver and glucoregulation: role of the hypothalamus and autonomic nerves. Nutrition 12: 65-66
15. 15. Saxena R, Theise ND, Crawford JM (1999) Microanatomy of the human liver-exploring the hidden interfaces. Hepatology 30: 1339-1346
16. 16. Landsberg L, Young JB (1992) Catecholamines and adrenal medulla. In: Wilson JD, Foster DW (eds) Williams textbook of Endocrinology, 8th edn. W. B. Saunders, Philadelphia, pp 621-706
17. 17. Bartness TJ, Bamshad M (1998) Innervation of mammalian white adipose tissue: implications for the regulation of total body fat. Am J Physiol 275: R1399-R1411
18. 18. Nonogaki K, Iguchi A (1997) Role of central neural mechanisms in the regulation of hepatic glucose metabolism. Life Sci 60: 797-807
19. 19. Nonogaki K, Iguchi A (1997) Stress, acute hyperglycemia and hyperlipidemia: role of autonomic nervous system and cytokines. Trends Endocrinol Metab 8: 192-197
20. 20. Gotoh M, Iguchi A, Yatomi A et al. (1989) Vagally mediated insulin secretion by stimulation of brain cholinergic neurons with neostigmine in bilateral adrenalectomized rats. Brain Res 493: 97-102
21. 21. Perseghin G, Regalia E, Battezzati A et al. (1997) Regulation of glucose homeostasis in humans with denervated livers. J Clin Invest 100: 931-941
22. 22. Chu C, Sindelar DK, Neal DW, Allen EJ, Donahue EP, Cherrington AD (1998) Effect of a selective rise in sinusoidal norepinephrine on HPG is due to an increase in glycogenolysis. Am J Physiol 274: E162-E171
23. 23. McGuinness OP, Shau V, Benson EM et al. (1997) Role of epinephrine and norepinephrine in the metabolic response to stress hormone infusion in the conscious dog. Am J Physiol 273: E674-E681
24. 24. Sudo M, Minokoshi Y, Shimazu T (1991) Ventromedial hypothalamic Stimulation enhances peripheral glucose uptake in anesthetized rats. Am J Physiol 261: E298-E303
25. 25. Minokoshi Y, Okano Y, Shimazu T (1994) Regulatory mechanism of the ventromedial hypothalamus in enhancing glucose uptake in skeletal muscles. Brain Res 649: 343-347
26. 26. Lang CH, Ajmal M, Baillie AGS (1995) Neural control of glucose uptake by skeletal muscle after central administration of NMDA. Am J Physiol 268: R492-R497
27. 27. Abe H, Minokoshi Y, Shimazu T (1993) Effect of a β3-adrenergic agonist, BRL35135A, on glucose uptake in rat skeletal muscle in vivo and in vitro. J Endocrinol 139: 479-486
28. 28. Liu YL, Cawthorne MA, Stock MJ (1996) Biophagic effects of the β-adrenoceptor agonist, BRL 37344, on glucose utilization in rat isolated skeletal muscle. Brit J Pharmacol 117: 1355-1361
29. 29. Klip A, Marette A (1992) Acute and chronic signals controlling glucose transport in muscle. J Cell Biochem 48: 51-60
30. 30. Tanishita T, Shimazu Y, Minokoshi Y, Shimazu T (1997) The β3-adrenergic agonist BRL37344 increases glucose transport into L6 myocytes through a mechanism different from that of insulin. J Biochem (Tokyo) 122: 90-95
31. 31. Granneman JG, Lahners KN, Chaudhry A (1991) Molecular cloning and expression of the rat β3-adrenergic receptor. Mol Pharmacol 40: 895-899
32. 32. Lelias JM, Kaghad M, Rodriguez M et al. (1993) Molecular cloning of a human β3-adrenergic receptor cDNA. FEBS Lett 324: 127-130
33. 33. Muzzin P, Revelli JP, Kuhne F et al. (1991) An adipose tissue-specific β-adrenergic receptor. J Biol Chem 266: 24053-24058
34. 34. Krief A, Lonnquist F, Raimbault S et al. (1993) Tissue distribution of β3-adrenergic receptor mRNA in man. J Clin Invest 91: 344-349
35. 35. De Souza CJ, Hirshman MF, Horton ES (1997) CL-316,243, a β3-specific adrenoceptor agonist, enhances insulin-stimulated glucose disposal in nonobese rats. Diabetes 46: 1257-1263
36. 36. Bonen A, Megeney LA, McCarthy SC, McDermott JC, Tan MH (1992) Epinephrine administration stimulates GLUT4 translocation but reduces glucose transport in muscle. Biochem Biophys Res Commun 187: 685-691
37. 37. Han X-X, Bonen A (1998) Epinephrine translocates GLUT-4 but inhibits insulin-stimulated glucose transport in rat muscle. Am J Physiol 274: E700-E707
38. 38. Laurent D, Petersen KF, Russell RR, Cline GW, Shulman GI (1998) Effect of epinephrine on muscle glycogenolysis and insulin-stimulated muscle glycogen synthesis in humans. Am J Physiol 274: E130-E138
39. 39. Jones JP, Dohm L (1997) Regulation of glucose transporter GLUT-4 and hexokinase II gene transcription by insulin and epinephrine. Am J Physiol 273: E682-E687
40. 40. Liu X, Perusse F, Bukowiecki LJ (1994) Chronic norepinephrine infusion stimulates glucose uptake in white and brown adipose tissues. Am J Physiol 266: R914-R920
41. 41. Kiu X, Perusse F, Bukowiecki LJ (1998) Mechanisms of the antidiabetic effects of the β3-adrenergic agonist CL-316243 in obese Zucker-ZDF rats. Am J Physiol 274: R1212-R1219
42. 42. Macaulay SL, Kelada ASM, Proietto J (1994) Isoproterenol inhibits cyclic AMP-mediated but not insulin-mediated translocation of the Glut-4 glucose transporter isoform. Mol Cell Biochem 141: 27-33
43. 43. Shimizu Y, Kielar D, Minokoshi Y, Shimazu T (1996) Noradrenaline increases glucose transport into brown adipocytes in culture by a mechanisms different from that of insulin. Biochem J 314: 485-490
44. 44. Lafontan M, Berlan M (1995) Fat cell α2-adrenocpetors: the regulation of fat cell function and lipolysis. Endocr Rev 1: 716-738
45. 45. Yurht A, Davis RC, Ong JM, Ranganathan G, Kern PA (1995) Regulation of lipoprotein lipase translation by epinephrine in3T3-L1 cells importance of the 3 ′ untranslated region. J Clin Invest 96: 2438-2444
46. 46. Kuusela P, Rehnmark S, Jacobsson A, Cannon B, Nedergaard J (1997) Adrenergic stimulation of lipoprotein lipase gene expression in rat brown adipocytes differentiated in culture: mediation via β3-and α1-adrenergic receptors. Biochem J 321: 759-767
47. 47. Himms-Hagen J, Cui J, Danforth E Jr et al. (1994) Effect of CL-316, 243, a thermogenic β3-agonist, on energy balance and brown and white adipose tissues in rat. Am J Physiol 266: R1371-R1382
48. 48. Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ (1997) Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 389: 374-377
49. 49. Liu L, Karkanias GB, Morales JC et al. (1998) Intracerebroventricular leptin regulates hepatic but not peripheral glucose fluxes. J Biol Chem 47: 31160-31167
50. 50. Burcelin R, Kamohara S, Li J, Tannenbaum GS, Charron MJ, Friedman JM (1999) Acute intravenous leptin infusion increases glucose turnover but not skeletal muscle glucosae uptake in ob/ob mice. Diabetes 48: 1264-1269
51. 51. Cohen B, Novick D, Rubinstein M (1996) Modulation of insulin activities by leptin. Science 274: 1185-1188
52. 52. Nemecz M, Preinneger K, Englisch R et al. (1999) Acute effect of leptin on hepatic glycogenolysis and gluconeogenesis in perfused rat liver. Hepatology 29: 166-172
53. 53. Berti L, Kellerer M, Capp E, Haring HU (1997) Leptin stimulates glucose transport and glycogen synthesis in C2C12 myotubes: evidence for PI-3-kinase-mediated effect. Diabetologia 40: 606-609
54. 54. Aiston S, Agius L (1999) Leptin enhances glycogen storage in hepatocytes by inhibition of phosphorylase and exerts an additive effect with insulin. Diabetes 48: 15-20
55. 55. Vaisse C, Halaas JL, Horvath CM, Darnell JE Jr, Stoffel M, Friedman JM (1996) Leptin activation of Stat3 in the hypothalamus of wild type and ob/ob mice but not db/db mice. Nat Genet 14: 95-97
56. 56. Minokoshi Y, Shahidul M, Shimazu T (1999) Microinjection of leptin into the ventromedial hypothalamus increases glucose uptake in peripheral tissues in rats. Diabetes 48: 287-291
57. 57. Haque MS, Minokoshi Y, Hamai M, Iwai M, Horiuchi M, Shimazu T (1999) Role of the sympathetic nervous system and insulin in enhancing glucose uptake in peripheral tissues after intrahypothalamic injection of leptin in rats. Diabetes 48: 1706-1712
58. 58. Wang J-L, Chinookoswong N, Scully S, QI M, Shi Z-G (1999) Differential effects of leptin in regulation of tissue glucose utilization in vivo. Endocrinology 140: 2117-2124
59. 59. Rouru J, Cusin I, Zakrzewska KE, Jeanrenaud B, Rohner-Jeanrenaud F (1999) Effects of intravenously infused leptin on insulin sensitivity and on the expression of uncoupling proteins in brown adipose tissue. Endocrinology 140: 3688-3692
60. 60. Sivitz WI, Walsh SA, Morgan DA, Thomas MJ, Haynes WG (1997) Effects of leptin on insulin sensitivity in normal rats. Endocrinology 138: 3395-3401
61. 61. Chinookoswong N, Wang J-L, Shi Z-Q (1999) Leptin restores euglycemic and normalizes glucose turnover in insulin-deficient diabetes in the rat. Diabetes 48: 1487-1492
62. 62. Muoio DM, Dohn GL, Friedorek FT Jr, Tapscott EB, Coleman RA (1997) Leptin directly alters lipid partitioning in skeletal muscle. Diabetes 46: 1360-1363
63. 63. Muller G, Ertl J, Gerl M, Preibisch G (1997) Leptin impairs metabolic actions of insulin in isolated rat adipocytes. J Biol Chem 272: 10585-10593
64. 64. Fei H, Okano HJ, Li C et al. (1997) Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. Proc Natl Acad Sci USA 94: 7001-7005
65. 65. Shimabukuro M, Koyama K, Chen G et al. (1997) Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci USA 94: 4637-4641
66. 66. Siegrist-Kaiser CA, Pauli V, Juge-Aubry CE et al. (1997) Direct effects of leptin on brown and white adipose tissue. J Clin Invest 100: 2858-2863
67. 67. Fruhbeck G, Aguado M, Martinez JA (1997) In vitro lipolytic effect of leptin on mouse adipocytes: evidence for a possible autocrine/paracrine role of leptin. Biochem Biophys Res Commun 240: 590-594
68. 68. Collins S, Kuhn CM, Petro AE, Swick AG, Chrunyk BA, Surwit RS (1996) Role of leptin in fat regulation. Nature 380: 677
69. 69. Harris RBS, Zhou J, Redmann SM Jr et al. (1998) A leptin dose-response study in obese (ob/ob) mice and lean (+/?) mice. Endocrinology 139: 8-19
70. 70. Halaas JL, Boozer C, Blair-West J, Fidahusein N, Denton DA, Friedman JM (1997) Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci USA 94: 8878-8883
71. 71. Scarpace PJ, Matheny M, Pollock BH, Tumer N (1997) Leptin increases uncoupling protein expression and energy expenditure. Am J Phsyiol 273: E226-E230
72. 72. Scarpace PJ, Matheny M (1998) Leptin induction of UCP1 gene expression is dependent on sympathetic innervation. Am J Physiol 275: E259-E264
73. 73. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI (1997) Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 100: 270-278
74. 74. Jansen ASP, Loewy HAD (1997) CNS sites involved in sympathetic and parasympathetic control of the pancreas: a viral tracing study. Brain Res 766: 29-38
75. 75. Bamshad M, Song CK, Bartness TJ (1999) CNS origins of the sympathetic nervous system outflow to brown adipose tissue. Am J Physiol 276: R1569-R1578
76. 76. Bamshad M, Aoki VT, Adkison MG, Warren WS, Bartness TJ (1998) Central nervous system origins of the sympathetic nervous system outflow to white adipose tissue. Am J Physiol 275: R291-R299
77. 77. McEwen BS (1998) Protective and damaging effects of stress mediators. N Engl J Med 338:171-179
78. 78. McEwen BS (1999) Estrogen actions in the central nervous system. Endocr Rev 20: 279-307
79. 79. McEwen BS (1999) The molecular and neuroanatomical basis for estrogen effects in the central nervous system. J Clin Endocrinol Metab 84:1790-1797
80. 80. Del Rio G, Velardo A, Menozzi R et al. (1998) Acute estradiol and progesterone administration reduced cardiovascular and catecholamine responses to mental stress in menopausal women. Neuroendocrinology 67: 269-274
81. 81. Saleh TM, Connell BJ (1999) Centrally mediated effect of 17β-estradiol on parasympathetic tone in male rats. Am J Physiol 276: R474-R481
82. 82. Satoh N, Ogawa Y, Katsuura G et al. (1999) Sympathetic activation of leptin via the ventromedial hypothalamus. Leptin-induced increase in catecholamine secretion. Diabetes 48: 1787-1793
83. 83. Sainsbury A, Rohner-Jeanrenaud F, Cusin I et al. (1997) Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinemia. Diabetologia 40: 1269-1277
84. 84. Dube MG, Xu B, Kalra PS, Sninsky CA, Kalra SP (1999) Disruption in neuropeptide Y and leptin signaling in obese ventromedial hypothalamic-lesioned rats. Brain Res 816: 38-46
85. 85. Satoh N, Ogawa Y, Katsuura G et al. (1997) Pathophysiological significance of the obese gene product, leptin, in ventromedial hypothalamus (VMH)-lesioned rats: evidence for loss of its satiety effect in VMH-lesioned rats. Endocrinology 138: 947-954
86. 86. Bergen HT, Monkman N, Mobbs CV (1996) Injection with gold thioglucose impairs sensitivity to glucose: evidence that glucose-responsive neurons are important for long-term regulation of body weight. Brain Res 734: 332-336
87. 87. Marks JL, Waite K, Cameron-Smith D, Blair SC, Cooney GJ (1996) Effects of glold thioglucose on neuropeptide Y messenger RNA levels in the mouse hypothalamus. Am J Physiol 270: R1208-R1214
88. 88. Bergen HT, Mizuno TM, Taylor J, Mobbs CV (1998) Hyperphagia and weight gain after gold-thioglucose:realtion to hypothalamic neuropeptide Y and proopiomelanocortin. Endocrinology 139: 4483-4488
89. 89. Choi S, Dallman MF (1999) Hypothalamic obesity: multiple routes mediated by loss of function in medial cell groups. Endocrinology 140: 4081-4088
90. 90. Choi S, Sparks R, Clay M, Dallman MF (1999) Rats with hypothalamic obesity are insensitive to central leptin injections. Endocrinology 140: 4426-4433
91. 91. Kesterson RA, Huszar D, Lynch CA, Simerly RB, Cone RD (1997) Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome. Mol Endocrinol 11: 630-637
92. 92. Mizuno TM, Kleopoulos SP, Bergen HT, Roberts JL, Priest CA, Mobbs CV (1997) Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting in ob/ob and db/db mice, but is stimulated by leptin. Diabetes 47: 294-297
93. 93. Schwartz MW, Seeley RJ, Woods SC et al. (1997) Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 46: 2119-2123
94. 94. Hakansson M-L, Brown H, Ghilardi N, Skoda RC, Meister B (1998) Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus. J Neurosci 18: 559-572
95. 95. Haynes WG, Morgan DA, Djalai A, Sivitz WI, Mark AL (1999) Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension 33: 542-547
96. 96. Lu D, Willard D, Patel IR et al. (1994) Agouti protein is an antagonist of the melanocyte-stimulating hormone receptor. Nature 371: 799-802
97. 97. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD (1994) Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 8: 1298-1308
98. 98. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD (1997) Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385: 165-168
99. 99. Boston BA, Blaydon KM, Varnerin J, Cone RD (1997) Independent and additive effects of central POMC and leptin pathways on murine obesity. Science 278: 1641-1644
100. 100. Huszar D, Lynch CA, Fairchild-Huntress V et al. (1997) Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88: 131-141
101. 101. Marsh DJ, Hollopeter G, Huszar D et al. (1999) Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides. Nat Genet 21: 119-122
102. 102. Chaouloff F (1993) Physiolpharmacological interactions between stress hormones and central serotonergic systems. Brain Res Brain Res Rev 18: 1-32
103. 103. Boetoo S, Richard D (1995) Functional assesment of the 5-HT1A-, 1B-, 2A/2C-, and 3-receptor subtypes on food intake and metabolic rate in rats. Am J Physiol 37: R14-R20
104. 104. Sugimoto Y, Yamada J, Yoshikawa T, Horisaka K (1996) Effects of the 5-HT2c/2B receptor agonist 1-(3-chlorophenyl) piperazine on plasma glucose level of rats. Eur J Pharmacol 307: 75-80
105. 105. Tecott LH, Sunn LM, Akana SF et al. (1995) Eating disorder and epilepsy in mice lacking 5-HT2c receptors. Nature 374: 542-546
106. 106. Nonogaki K, Strack AM, Dallman MF, Tecott LH (1998) Leptin-independent hyperphagia and type 2 diabetes in mice mutated serotonin 5-HT2c receptor gene. Nat Med 4: 1152-1156
107. 107. Wright DE, Seroogy KB, Lundgren KH, Davis BM, Jennes L (1995) Comparative localiztion of serotonin 1A,1C and 2 receptor subtype mRNAs in rat brain. J Comp Neurol 351: 357-373
108. 108. Susulic VS, Frederich RC, Iwaitts J et al. (1995) Targeted disruption of the β3-adrenergic receptor gene. J Biol Chem 270: 29483-29492
109. 109. Collins S, Daniel KW, Rohlfs EM, Ramkumar V, Taylor IL, Gettys TE (1994) Impaired expression and functional activity of the β3 and β1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6J ob/ob) mice. Mol Endocrinol 8: 518-527
110. 110. Revelli J-P, Preitner F, Samec S et al. (1997) Targeted gene disruption reveals a leptin-independent role for the mouse β3-adrenoceptor in the regulation of body composition. J Clin Invest 100: 1098-11106
111. 111. Enerback S, Jacobsson A, Simpson EM et al. (1997) Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese. Nature 387: 90-99
112. 112. Strosberg AD, Issad T (1999) The involvement of leptin in humans revealed by mutations in leptin and leptin receptor genes. Trends Pharmacol Sci 20: 227-230
113. 113. Gu W, Tu Z, Kleyn PW, Kissebah A et al. (1999) Identification and functional analysis of novel human melanocortin-4 receptor varients. Diabetes 48: 635-639
114. 114. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A (1998) Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 19: 155-157
115. 115. Walston J, Siver K, Boagardus C et al. (1995) Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the β3-adrenergic receptor gene. N Engl J Med 333: 343-347
116. 116. Widen E, Letto M, Kanninen T, Walston J, Shuldiner AR, Groop LC (1995) Association of a polymorphism in the β3-adrenergic receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 333: 348-351
117. 117. Clement K, Vaisse C, Manning BSJ et al. (1995) Genetic variation in the β3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 333: 352-354
118. 118. Yoshida T, Sakane N, Umekawa T, Sakai Y, Takahashi T, Kondo M (1995) Mutation of β3-adrenergic receptor gene and response to treatment of obesity. Lancet 46: 1433-1434
119. 119. Sakane N, Yoshida T, Umekawa T, Kogure A, Takakura Y, Kondo M (1997) Effects of Trp64Arg mutation in the β3-adrenergci receptor gene on weight loss, body fat distribution, glycemic control, and insulin resistance in obese type 2 diabetic patients. Diabetes Care 20: 1887-1890
120. 120. Kadowaki H, Kosaka K, Yamada N et al. (1995) A mutation in the β3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Commun 215: 555-560
121. 121. Fujisawa T, Ikegami H, Kawaguchi Y, Ogihara T (1998) Meta-analysis of the association of Trp64Arg polymorphism of β3-adrenergic receptor gene with body mass index. J Clin Endocrinol Metabo 83: 2441-2444
122. 122. Umekawa T, Yoshida T, Sakane N, Kogure A, Kondo M, Honjyo H (1999) Trp64Arg mutation of β3-adrenoceptor gene deteriorates lipolysis induced by β3-adrenoceptor agonist in human omental adipocytes. Diabetes 48: 117-120
123. 123. Arner P, Hoffstedt J (1999) Adrenoceptor genes in human obesity. J Intern Med 245: 667-672
124. 124. Weyer C, Tataranni PA, Snitker S, Danforth E Jr, Ravussin E (1998) Increase in insulin action and fat oxidation after treatment with CL316,243, a highly selective β3-adrenoceptor agonist in humans. Diabetes 47: 1555-1561
125. 125. Large V, Hellstrom L, Reynisdottir S et al. (1997) Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associated with altered adipocyte beta-2 adrenoceptor function. J Clin Invest 100: 3005-3013